Zomedica Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.063; its P/E ratio is ―; Zomedica Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 7.00M	$ 6.13M	$ 6.26M	$ 7.34M	$ 6.35M
Gross Profit	$ 5.06M	$ 4.36M	$ 4.12M	$ 5.07M	$ 4.36M
EBIT	$ -6.72M	$ -24.07M	$ -9.33M	$ -21.95M	$ -2.35M
EBITDA	$ -4.70M	$ -22.10M	$ -7.39M	$ -19.89M	$ -751.00K
Net Income Common Stockholders	$ -6.70M	$ -23.93M	$ -9.16M	$ -22.40M	$ -491.00K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 76.88M	$ 79.51M	$ 82.96M	$ 90.50M	$ 106.21M
Total Assets	$ 214.12M	$ 219.88M	$ 243.70M	$ 253.20M	$ 275.05M
Total Debt	$ 2.08M	$ 2.29M	$ 2.50M	$ 2.73M	$ 1.75M
Net Debt	$ -74.80M	$ -77.22M	$ -80.46M	$ -87.77M	$ -104.45M
Total Liabilities	$ 11.27M	$ 11.16M	$ 11.81M	$ 13.18M	$ 14.17M
Stockholders Equity	$ 202.84M	$ 208.72M	$ 231.90M	$ 240.02M	$ 260.88M
Cash Flow	-
Free Cash Flow	$ -5.88M	$ -7.99M	$ -9.95M	$ -7.08M	$ -9.55M
Operating Cash Flow	$ -4.80M	$ -6.72M	$ -7.59M	$ -5.01M	$ -3.03M
Investing Cash Flow	$ 6.54M	$ 3.77M	$ 5.63M	$ -3.83M	$ -3.12M
Financing Cash Flow	$ -70.00K	-	-	-	-

Currency in USD

Zomedica Pharmaceuticals Earnings and Revenue History

Income Statement >

Zomedica Pharmaceuticals Debt to Assets

Balance Sheet >

Zomedica Pharmaceuticals Cash Flow

Cash Flow >

Zomedica Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing